Skip to main content
Log in

Correlation of tumour and treatment characteristics to dose received by cochlea in volumetric arc therapy

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

This is a radiation field simulation study using CT images designed to see the cochlear dosimetry and its correlation with tumour and treatment characteristics during radiotherapy for head and neck cancers (HNC) for identifying the factors associated with a higher dose delivered to the cochlea.

Methods

From 2018 to 2020, 80 patients with HNC underwent volumetric arc therapy (VMAT) to a dose of 66–70 Gy at 2 Gy per fraction with bilateral cochlea contoured for VMAT optimization as an organ at risk. Minimum, mean and maximum planned radiation dose to the cochlea based on tumour and treatment characteristics and dose-volume histogram variables of VMAT plans were analysed.

Results

Mean (standard deviation, SD) cochlear volume was 0.14 (0.06) cm3 with maximum and mean planned doses of 10.3 (SD = 11.6) Gy and 8.5 (SD = 9.8) Gy, respectively. We found a statistically significant correlation between mean dose received by bilateral cochlea (P—0.000, rright—0.84, rleft—0.78, rmidline—0.92). Tumours of the paranasal sinuses, and the parotids and more advanced T stages were associated with a higher mean dose to cochlea but was not significant statistically. The dose received by the 95% target nodal volume (D95%) showed a significant correlation with the cochlear mean dose (P—0.000, rright—0.85, rleft—0.77, rmidline—0.93)

Conclusion

With VMAT we have achieved a better sparing of cochlea. The mean dose to the cochlea of one side significantly differed from the other side in patients with lateralized cancers. D95% of nodal volume also showed a significant correlation with the cochlear mean dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Shah S, Sharma S, D’Cruz A (2016) Head and neck oncology: The Indian scenario. South Asian J Cancer 5:104. https://doi.org/10.4103/2278-330X.187572

    Article  PubMed  PubMed Central  Google Scholar 

  2. Prabhash K, Babu G, Chaturvedi P et al (2020) Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and neck. Indian J Cancer 57(5):22. https://doi.org/10.4103/0019-509X.278977

    Article  Google Scholar 

  3. Feng L, Qi S, Lin M (2018) Efficacy and survival rate of intensity-modulated radiotherapy combined with chemotherapy for elderly patients with locally advanced oropharyngeal cancer. Exp Ther Med 15(3):2475–2479. https://doi.org/10.3892/etm.2017.5682

    Article  CAS  PubMed  Google Scholar 

  4. Zhang C, Liu L-X, Li W-Z et al (2019) Cochlea sparing with a stratified scheme of dose limitation employed in intensity-modulated radiotherapy for nasopharyngeal carcinoma: A dosimetry study. Med Dosim Off J Am Assoc Med Dosim 44(3):226–232. https://doi.org/10.1016/j.meddos.2018.08.003

    Article  Google Scholar 

  5. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A (2011) Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 84(1007):967–996. https://doi.org/10.1259/bjr/22373346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Petsuksiri J, Sermsree A, Thephamongkhol K et al (2011) Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiat Oncol 6(1):19. https://doi.org/10.1186/1748-717X-6-19

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bhide SA, Newbold KL, Harrington KJ, Nutting CM (2012) Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol 85(1013):487–494. https://doi.org/10.1259/bjr/85942136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Merlotti A, Alterio D, Vigna-Taglianti R et al (2014) Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. Radiat Oncol Lond Engl. https://doi.org/10.1186/s13014-014-0264-9

    Article  Google Scholar 

  9. Sun Y, Yu X-L, Luo W et al (2014) Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 110(3):390–397. https://doi.org/10.1016/j.radonc.2013.10.035

    Article  Google Scholar 

  10. Dautremont JF, Brake MK, Thompson G, Trites J, Hart RD, Taylor SM (2012) Planned neck dissection following radiation treatment for head and neck malignancy. Int J Otolaryngol. https://doi.org/10.1155/2012/954203

    Article  PubMed  PubMed Central  Google Scholar 

  11. Grégoire V, Ang K, Budach W et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol J Eur Soc Ther Radiol Oncol. https://doi.org/10.1016/j.radonc.2013.10.010

    Article  Google Scholar 

  12. Brouwer CL, Steenbakkers RJHM, Bourhis J et al (2015) CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol J Eur Soc Ther Radiol Oncol 117(1):83–90. https://doi.org/10.1016/j.radonc.2015.07.041

    Article  Google Scholar 

  13. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2009) Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 73(3):779–788. https://doi.org/10.1016/j.ijrobp.2008.05.040

    Article  CAS  PubMed  Google Scholar 

  14. Sarin V (2019) Adverse cochlear effects after head and neck cancer therapy. Indian J Otolaryngol Head Neck Surg 71(Suppl 1):740–747. https://doi.org/10.1007/s12070-018-1532-z

    Article  PubMed  Google Scholar 

  15. Ferlito A, Rinaldo A, Devaney KO et al (2002) Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol 38(8):747–751. https://doi.org/10.1016/s1368-8375(02)00052-0

    Article  PubMed  Google Scholar 

  16. Shah JP (1990) Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 160(4):405–409. https://doi.org/10.1016/s0002-9610(05)80554-9

    Article  CAS  PubMed  Google Scholar 

  17. Bhandare N, Jackson A, Eisbruch A et al (2010) Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 76(3 Suppl):S50-57. https://doi.org/10.1016/j.ijrobp.2009.04.096

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bentzen SM, Constine LS, Deasy JO et al (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76(3 Suppl):S3–S9. https://doi.org/10.1016/j.ijrobp.2009.09.040

    Article  PubMed  PubMed Central  Google Scholar 

  19. Paulino AC, Lobo M, Teh BS et al (2010) Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 78(5):1445–1450. https://doi.org/10.1016/j.ijrobp.2009.09.031

    Article  CAS  PubMed  Google Scholar 

  20. Herrmann F, Dörr W, Müller R, Herrmann T (2006) A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 65(5):1338–1344. https://doi.org/10.1016/j.ijrobp.2006.03.032

    Article  PubMed  Google Scholar 

  21. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR (2005) Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61(5):1393–1402. https://doi.org/10.1016/j.ijrobp.2004.08.019

    Article  PubMed  Google Scholar 

  22. Ho WK, Wei WI, Kwong DL et al (1999) Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck 21(6):547–553. https://doi.org/10.1002/(sici)1097-0347(199909)21:6%3c547::aid-hed8%3e3.0.co;2-y

    Article  CAS  PubMed  Google Scholar 

  23. Zhang J, Qureshi MM, Kovalchuk N, Truong MT (2014) Correlating planned radiation dose to the cochlea with primary site and tumor stage in patients with head and neck cancer treated with intensity-modulated radiation therapy. Med Dosim 39(1):88–92. https://doi.org/10.1016/j.meddos.2013.10.004

    Article  PubMed  Google Scholar 

  24. Padma R, Kalaivani A, Sundaresan S, Sathish P (2017) The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol JOMFP 21(3):461. https://doi.org/10.4103/jomfp.JOMFP_241_16

    Article  PubMed  Google Scholar 

  25. van der Putten L, de Bree R, Plukker JT et al (2006) Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 28(10):902–908. https://doi.org/10.1002/hed.20426

    Article  PubMed  Google Scholar 

  26. Honoré HB, Bentzen SM, Møller K, Grau C (2002) Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol J Eur Soc Ther Radiol Oncol 65(1):9–16. https://doi.org/10.1016/s0167-8140(02)00173-1

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

All authors declare that there is no funding involved in this study.

Author information

Authors and Affiliations

Authors

Contributions

All authors were equally involved in conception of the work, data collection, data analysis and interpretation, drafting the article, critical revision of the article, and final approval of the version to be published. Statistical analysis is done by second author.

Corresponding author

Correspondence to Amit Goyal.

Ethics declarations

Ethics approval

The present study was approved by institutional ethical committee—All India Institute of Medical Sciences Jodhpur, Rajasthan, India (AIIMS/IEC/2018/827).

Consent to participate

Patients were enrolled after obtaining informed consent for participation.

Consent for publication

Patients were enrolled after obtaining informed consent for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 22 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Das, N., Patro, S.K., Kaushal, D. et al. Correlation of tumour and treatment characteristics to dose received by cochlea in volumetric arc therapy. Eur Arch Otorhinolaryngol 279, 2019–2028 (2022). https://doi.org/10.1007/s00405-021-06950-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06950-y

Keywords

Navigation